GE9 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Genmab A/S

Watchlist Manager

Watchlist

Price: 490.8 EUR -0.85% Market Closed

Market Cap: €30.2B

G	Genmab A/S F:GE9	DK
D	Daiwa House Industry Co Ltd DUS:DWH	JP
	Microsoft Corp NASDAQ:MSFT	US
	Sun International Ltd F:RY1B	ZA
P	Pfizer Inc BMV:PFE	US
A	AstraZeneca PLC XMUN:ZEG	UK

Profitability Summary

Genmab A/S's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

95%

Gross Margin is Increasing

70% > 93%

Exceptional Operating Margin

32%

Strong 3Y Average Operating Margin

33%

Declining Operating Margin

36% > 32%

Healthy Net Margin

19%

Sustainable 3Y Average Net Margin

30%

Declining Net Margin

25% > 19%

Exceptional Free Cash Flow Margin

21%

Strong 3Y Average Free Cash Flow Margin

31%

Declining Free Cash Flow Margin

34% > 21%

Positive ROE

14%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

34%

Declining ROIC

70% > 16%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.